Avril Dieser
Net worth: 10 700 $ as of 2026-05-30
Net worth: 10 700 $ as of 2026-05-30
Avril McKean Dieser is an Independent Non-Executive Director at OS Therapies, Inc. since 2024.
Ms. Dieser is Vice President & Head-Legal Patient Evidence at UCB, Inc. since 2016.
Ms. Dieser was a Member at AbbVie, Inc. from 2013 to 2016.
Ms. Dieser completed graduate degrees at the University of Maryland and Columbus School of Law, and an undergraduate degree at Duquesne University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-21 | 5,000 ( 0.01% ) | 10 700 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| OS THERAPIES INCORPORATED | Director/Board Member | 2024-10-27 |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 2016-07-31 |
| Companies | Position | End |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 2016-06-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Columbus School of Law
Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OS Therapies, Inc.
OS Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical stage therapeutic company engages in development and commercialization of treatments for osteosarcoma | Health Technology |
Select your edition
All financial news and data tailored to specific country editions